Hot Life Science Investor Mandate 3:Family Office Seeking Innovative Therapies Targeting Cystic Fibrosis

25 Jun

A family office investment firm based in the Eastern United States specifically focuses on therapeutics for Cystic Fibrosis, including Adult Stem Cell Therapy. The firm manages an evergreen fund and can provide between $200K and $1M in equity per company. The firm has no specific requirement regarding where the company is located and is actively seeking new investment opportunities.

The firm is interested in all therapies for cystic fibrosis, including adult stem cell therapy. The firm looks for early-stage companies with products in pre-clinical or clinical development. Therapies for cystic fibrosis may include antibiotics, anti-inflammatories, airway surface hydrators, CFTR-modulating treatments, and others.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: